meta in uganda
DESCRIPTION
Presentation on the background to MeTA initiative in Uganda and the shape of MeTA Uganda.TRANSCRIPT
CSO Workshop Sunset Hotel
26 April 2009
Medicines Transparency Alliance(MeTA) Uganda
Presentation Overview
Background to MeTA initiative in Uganda
o Sequence of events and consultations
o Stakeholder perspectives on MeTA priorities for improved access to medicines
The shape of MeTA in Uganda
o Structures: Council, Secretariat, Fund holder
o MoU and Work plan
Mar-09MeTA Uganda Briefing2
Brief History of MeTA Uganda (2007- 2008)
Scoping study & supply chain study in 2007 MOH accept invitation to join as a MeTA pilot country CSO members attended capacity building workshop in
Uganda (Feb. 2008) Multi-stakeholder attendance from Uganda at global
launch (May 2008) Int’l Secretariat visit (Oct. 2008) Short-term TA contracted to support pre-launch
processes Private sector mapping by Int’l consultant (Dec. 2008)
Mar-093
Need for info on medicines market / demand– Most stakeholders agree on info sharing, disclosure
Pricing policy, e.g. recomm. / max. retail price– Agreement in the case of essential medicines;
lower price=higher access= increased sales
Import of generics vs local manufacture– S/Hs differ on strategic value of local manuf;
GI conditionalities = better quality or barrier?
Perspectives – Private Sector
Mar-094
Transparency in the supply chain– Procurement and supply management information
in the public domain
CSO representation at all levels– Enhanced accountability; reduced pilferage
Capacity building for effectiveness– Players in supply chain, n.b. health facility level– CSO participation from policy level to community
Perspectives – Civil Society
Mar-095
Poor medicines availability in public facilities Under funding of medicines
– 30% of the requirement for UNMHCP; escalating cost due to scale up of programmes needing expensive medicines (ARVs, ITNs, ACTs)
Weak proc. and supply management systems – At all levels; concerns over VFM/ quality in local
private sector purchases/ excessive retail mark-ups; reports of leakage
Perspectives – Government
Mar-096
Lead up to Launch (2009)
Formal establishment of National Multi-Stakeholder Council
National MeTA Secretariat streamlined and Coordinator recruited
Fund-holder arrangement MoU signed for implementation of country work
plan
Mar-097
Activity StakeholdersPeriodic surveys of medicines prices and availability
MoH, CSOs, WHO
Web-based information on registration, quality, volumes and FOB cost of medicines
NDA, PS (Manuf/Importers)
Evaluation of the rolling plan for provision of medicines for the UNMCHP (FY 08-09)
Gov, Dev. Partners, Implem Agencies, TWG
Outputs – transparency and information disclosure
Mar-098
Activity StakeholdersStop the stock-outs campaign CSOs
Multi-stakeholder follow-up of recommendations of the tracking study, periodic surveys and performance evaluation
Gov, CS, TWG
Outputs – accountability and good governance
Mar-099
Activity StakeholdersPilot awareness campaign on approp. use of medicines in communities and train drug handlers
CSOs, PSU
Contribute to IEC strategies and messages at national level
Multi-stakeholder
Radio talk shows, jingles Multi-stakeholder
Outputs – IEC & awareness
Mar-0910
Activity StakeholdersBuild capacity in at least 30 CSOs to effectively participate in improved governance, transparency and accountability in medicines supply chain
Expanded CS-MeTA alliance
Engage policy makers on the issue of low availability / high stock-outs of medicines
MoH, MoFPED, LG, Parliament, AG, PPDA, NDA, NMS
Outputs – CSO capacity building
Mar-0911
Summary - MeTA
Global initiative to improve access to medicines through increased transparency & accountability
Governed by national & international multi-stakeholder forums
Progressive disclosure of data collected / information reported = key outcome of pilot
Mar-0912
Thank you!
Questions, comments …????
More about MeTA: www.MedicinesTransparency.org
Mar-09MeTA Uganda Launch13